AU1028001A - Secretin fragments for treating autism - Google Patents

Secretin fragments for treating autism

Info

Publication number
AU1028001A
AU1028001A AU10280/01A AU1028001A AU1028001A AU 1028001 A AU1028001 A AU 1028001A AU 10280/01 A AU10280/01 A AU 10280/01A AU 1028001 A AU1028001 A AU 1028001A AU 1028001 A AU1028001 A AU 1028001A
Authority
AU
Australia
Prior art keywords
treating autism
secretin
fragments
secretin fragments
autism
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU10280/01A
Inventor
Artur Frank
Wilfried Hiebl
Karl Jordan
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
GOLDHAM PHARMA GmbH
Original Assignee
GOLDHAM PHARMA GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by GOLDHAM PHARMA GmbH filed Critical GOLDHAM PHARMA GmbH
Publication of AU1028001A publication Critical patent/AU1028001A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/645—Secretins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Endocrinology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Hospice & Palliative Care (AREA)
  • Toxicology (AREA)
  • Molecular Biology (AREA)
  • Psychiatry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
AU10280/01A 1999-11-05 2000-11-03 Secretin fragments for treating autism Abandoned AU1028001A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE19953339 1999-11-05
DE19953339A DE19953339A1 (en) 1999-11-05 1999-11-05 Secret fragments
PCT/EP2000/010847 WO2001032196A1 (en) 1999-11-05 2000-11-03 Secretin fragments for treating autism

Publications (1)

Publication Number Publication Date
AU1028001A true AU1028001A (en) 2001-05-14

Family

ID=7928059

Family Applications (1)

Application Number Title Priority Date Filing Date
AU10280/01A Abandoned AU1028001A (en) 1999-11-05 2000-11-03 Secretin fragments for treating autism

Country Status (3)

Country Link
AU (1) AU1028001A (en)
DE (1) DE19953339A1 (en)
WO (1) WO2001032196A1 (en)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6921751B1 (en) 1998-05-20 2005-07-26 Erasmus Universiteit Rotterdam Immunoregulator
US7175679B2 (en) 2001-03-29 2007-02-13 Biotempt B.V. Oligopeptide treatment of NF-κB mediated inflammation
US20030220258A1 (en) 2001-12-21 2003-11-27 Robbert Benner Treatment of ischemic events
US6844315B2 (en) 1998-05-20 2005-01-18 Erasmus Universiteit Rotterdam Immunoregulator
US8680059B2 (en) 1998-05-20 2014-03-25 Biotempt B.V. Oligopeptide acetate and formulations thereof
EP1300418A1 (en) 2001-10-04 2003-04-09 Erasmus Universiteit Rotterdam Gene regulation by oligopeptides
US7576174B2 (en) 2000-03-29 2009-08-18 Biotempt B.V. Compositions capable of reducing elevated blood urea concentration
US7358330B2 (en) 2001-03-29 2008-04-15 Biotempt B.V. Immunoregulatory compositions
USRE43279E1 (en) 2000-03-29 2012-03-27 Biotemp B.V. Compositions capable of reducing elevated blood urea concentration
US7786084B2 (en) 2001-12-21 2010-08-31 Biotempt B.V. Treatment of burns
US7501391B2 (en) 2001-12-21 2009-03-10 Biotempt B.V. Treatment of transplant survival
US7517529B2 (en) 2003-04-08 2009-04-14 Biotempt B.V. Treatment of type I diabetes
US8524665B2 (en) 2003-05-13 2013-09-03 The Mclean Hospital Corporation Use of secretin in treatments of disorders associated with the amygdala
WO2007004869A2 (en) 2005-07-05 2007-01-11 Biotempt B.V. Treatment of tumors
EP1864692A1 (en) 2006-06-07 2007-12-12 Biotempt B.V. Use of peptides for the control of radiation injury

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4086220A (en) * 1976-08-09 1978-04-25 G. D. Searle & Co. Fragments of secretin
AU748147B2 (en) * 1997-05-19 2002-05-30 Repligen Corporation Method for assisting in differential diagnosis and treatment of autistic syndromes

Also Published As

Publication number Publication date
DE19953339A1 (en) 2001-05-17
WO2001032196A1 (en) 2001-05-10

Similar Documents

Publication Publication Date Title
AU6908500A (en) Treatment for narcolepsy
AU4484200A (en) Method for grinding glass
AU6777300A (en) Treatment apparatus for wounds
AU1294401A (en) Methods for treating fibroproliferative diseases
EP1176964B8 (en) Uses of et743 for treating cancer
AU6697200A (en) Lyophilization method
AU4652400A (en) Method for grinding glass
AU773240C (en) Medicament for treating hypertension
AU1028001A (en) Secretin fragments for treating autism
AU1952601A (en) Estrogens for treating als
AU2695300A (en) Waste treating method
AU1772399A (en) Well treatment
AU1538901A (en) Polymersation process
AU1335201A (en) Hydrodesulfurization process
AU7363000A (en) Method for reducing the risk of cancer
AU5547000A (en) Novel treatment
AU1321601A (en) Multiple source location method
AUPQ232599A0 (en) Drug for treating fractures
AU4556800A (en) Novel treatment
AU2002216930A1 (en) System for treating vascular adhesions
AU1972200A (en) Treatment for fabrics
AU4647800A (en) Ozone enhancing system
AU3988099A (en) Combination therapy for treating hypercholesterolemia
AU6234000A (en) Methods for treating autoimmune diseases
AU5097099A (en) Methods and compositions for cancer treatment

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase